易天股份(300812.SZ):全自動柔性面板偏光片貼附設備已經取得了包括京東方、維信諾、深天馬、華星光電等客户的認可
格隆匯6月30日丨易天股份(300812.SZ)於投資者互動平台表示,在柔性OLED顯示設備領域,公司研發並推出的全自動柔性面板偏光片貼附設備,已經取得了包括京東方、維信諾、深天馬、華星光電等客户的認可。研發並推出的柔性面板製作工藝中所需的膜材貼附設備,如面板取下前清洗設備、取下後覆膜設備等相關設備也獲得了華星光電等客户的認可。依託於在面板貼附領域的領先技術,公司已成為國內柔性面板製造廠商的首選合作廠商之一,且獲得相關客户的一致好評。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.